INTERNATIONAL COUNCIL FOR STANDARDIZATION IN HAEMATOLOGY
The ICSH is a not-for-profit organisation that aims to achieve reliable and reproducible results in laboratory analysis in the field of diagnostic haematology.The ICSH coordinates Working Groups of experts to examine laboratory methods and instruments for haematological analyses, to deliberate on issues of standardization and to stimulate and coordinate scientific work as necessary towards the
Financial health, per its FY2024 accounts
The accounts state that the charity held total funds of £230,897 at the year end, representing a surplus of £15,136 for the period. The trustees consider the charity to be in a solid financial position with cash held in UK bank accounts. No material uncertainties or risks to continuing operations were disclosed.
What the accounts disclose
“Reserves are maintained: to allow investment in suitable laboratory haematology projects; to support scientific research around the globe; to support our participation, stakeholding and collaborative relationships with external International bodies; and to ensure the charitable company has sufficient resources to continue as a going concern and conduct annual General Assembly meetings.” — page 3
Trustees
- WENDY NAOMI ERBERchair
- Dr Amrom Obstfeld
- Dr Benjamin Derek Hedley
- Dr CORNELIUS LEONARD HARTEVELD
- Dr Ian James Mackie
- Dr Jin-Yeong Han
- Dr Michelle Grant
- Dr Olga Pozdnyakova
- Dr STEPHEN KITCHEN
- Richard Paul McCafferty
- Simon John Davidson
- Stephen Grant MacDonald
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £101k | £86k |
| 31/12/2023 | £88k | £82k |
| 31/12/2022 | £69k | £108k |
| 31/12/2021 | £73k | £45k |
| 31/12/2020 | £228k | £56k |
Common questions
Is INTERNATIONAL COUNCIL FOR STANDARDIZATION IN HAEMATOLOGY financially healthy?
Per its FY2024 accounts: The accounts state that the charity held total funds of £230,897 at the year end, representing a surplus of £15,136 for the period. The trustees consider the charity to be in a solid financial position with cash held in UK bank accounts. No material uncertainties or risks to continuing operations were disclosed. Its FY2024 accounts were independently examined.